Regulation of cardiovascular calcification

被引:166
作者
Speer, MY [1 ]
Giachelli, CM [1 ]
机构
[1] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
关键词
modulator; mutant mouse; regulation; vascular calcification;
D O I
10.1016/S1054-8807(03)00130-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular calcification is highly correlated with cardiovascular disease (CVD) and is a significant predictor of cardiovascular events, especially in high risk patients such as the end stage renal disease (ESRD) population. Vascular calcification can lead to serious problems including valve stenosis, decreased vascular compliance, calciphylaxis, and even sudden death. However, the contribution of vascular calcification to progression of atherosclerosis is unknown and needs more study. Biochemical, histological, and genetic studies indicate that vascular calcification is actively regulated and involves both positive and negative modulators. Several nonmutually exclusive theories to account for vascular calcification based on current studies are discussed. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 101 条
[1]   Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells [J].
Ahmed, S ;
O'Neill, KD ;
Hood, AF ;
Evan, AP ;
Moe, SM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (06) :1267-1276
[2]   Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption [J].
Aubin, JE ;
Bonnelye, E .
OSTEOPOROSIS INTERNATIONAL, 2000, 11 (11) :905-913
[3]  
Balica M, 1997, CIRCULATION, V95, P1954
[4]   EFFECT OF DEGENERATIVE SPINAL AND AORTIC CALCIFICATION ON BONE-DENSITY MEASUREMENTS IN POSTMENOPAUSAL WOMEN - LINKS BETWEEN OSTEOPOROSIS AND CARDIOVASCULAR-DISEASE [J].
BANKS, LM ;
LEES, B ;
MACSWEENEY, JE ;
STEVENSON, JC .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (12) :813-817
[5]  
BEADENKOPF WG, 1964, AMER J ROENTGENOL RA, V92, P865
[6]   Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease [J].
Blacher, J ;
Demuth, K ;
Guerin, AP ;
Safar, ME ;
Moatti, N ;
London, GM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) :535-541
[7]  
Blair HC, 1998, BIOESSAYS, V20, P837, DOI 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO
[8]  
2-D
[9]   A phenocopy of CAII deficiency: a novel genetic explanation for inherited infantile osteopetrosis with distal renal tubular acidosis [J].
Borthwick, KJ ;
Kandemir, N ;
Topaloglu, R ;
Kornak, U ;
Bakkaloglu, A ;
Yordam, N ;
Ozen, S ;
Mocan, H ;
Shah, GN ;
Sly, WS ;
Karet, FE .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (02) :115-121
[10]   BONE MORPHOGENETIC PROTEIN EXPRESSION IN HUMAN ATHEROSCLEROTIC LESIONS [J].
BOSTROM, K ;
WATSON, KE ;
HORN, S ;
WORTHAM, C ;
HERMAN, IM ;
DEMER, LL .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1800-1809